These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27489047)

  • 1. Papilloedema secondary to oligodendroglioma.
    Roncone DP
    Clin Exp Optom; 2016 Nov; 99(6):507-517. PubMed ID: 27489047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligodendrogliomas: impact of molecular genetics on treatment.
    Hartmann C; von Deimling A
    Neurol India; 2005 Jun; 53(2):140-8. PubMed ID: 16010049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New treatment paradigm for patients with anaplastic oligodendroglial tumors.
    Polivka J; Polivka J; Rohan V; Topolcan O
    Anticancer Res; 2014 Apr; 34(4):1587-94. PubMed ID: 24692686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gliomas with 1p/19q codeletion: a.k.a. oligodendroglioma.
    Cairncross G; Jenkins R
    Cancer J; 2008; 14(6):352-7. PubMed ID: 19060598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Loss of heterozygosity on chromosomes 1 and 19 in cases of primary brain tumour].
    Born PW; Broholm H; Laursen H
    Ugeskr Laeger; 2006 Oct; 168(44):3813-6. PubMed ID: 17118240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligodendroglioma--a case presentation.
    Raciti-Daurio C; Caruso J
    Optom Vis Sci; 1990 Jan; 67(1):56-8. PubMed ID: 2308753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumours.
    Jenkinson MD; Smith TS; Joyce KA; Fildes D; Broome J; du Plessis DG; Haylock B; Husband DJ; Warnke PC; Walker C
    Neuroradiology; 2006 Oct; 48(10):703-13. PubMed ID: 16937145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-grade and anaplastic oligodendroglioma.
    Van Den Bent MJ; Bromberg JE; Buckner J
    Handb Clin Neurol; 2016; 134():361-80. PubMed ID: 26948366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity analysis in an anaplastic oligodendroglioma arising after radiation therapy.
    Hata N; Shono T; Mizoguchi M; Matsumoto K; Guan Y; Nagata S; Hayashi K; Iwaki T; Sasaki T
    Neurol Res; 2007 Oct; 29(7):723-6. PubMed ID: 17553214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granular cells in oligodendroglioma suggest a neoplastic change rather than a reactive phenomenon: case report with molecular characterisation.
    Rao S; Sravya P; Chandran C; Saini J; Somanna S; Santosh V
    Brain Tumor Pathol; 2017 Jan; 34(1):42-47. PubMed ID: 27738816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological growth patterns and genotype in oligodendroglial tumours: correlation with MRI features.
    Jenkinson MD; du Plessis DG; Smith TS; Joyce KA; Warnke PC; Walker C
    Brain; 2006 Jul; 129(Pt 7):1884-91. PubMed ID: 16670176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of molecular and clinical factors on patient outcome in oligodendroglioma from 20 years' experience at a single centre.
    Parkinson JF; Afaghi V; Payne CA; Buckland ME; Brewer JM; Biggs MT; Little NS; Wheeler HR; Cook RJ; McDonald KL
    J Clin Neurosci; 2011 Mar; 18(3):329-33. PubMed ID: 21247767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.
    Dubbink HJ; Atmodimedjo PN; Kros JM; French PJ; Sanson M; Idbaih A; Wesseling P; Enting R; Spliet W; Tijssen C; Dinjens WN; Gorlia T; van den Bent MJ
    Neuro Oncol; 2016 Mar; 18(3):388-400. PubMed ID: 26354927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcoma-like tumor originating from oligodendroglioma.
    Shoji T; Saito R; Kanamori M; Sonoda Y; Watanabe M; Tominaga T
    Brain Tumor Pathol; 2016 Oct; 33(4):255-260. PubMed ID: 27333891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric glioblastoma with oligodendroglioma component: aggressive clinical phenotype with distinct molecular characteristics.
    Mizoguchi M; Hata N; Suzuki SO; Fujioka Y; Murata H; Amano T; Nakamizo A; Yoshimoto K; Iwaki T; Sasaki T
    Neuropathology; 2013 Dec; 33(6):652-7. PubMed ID: 23530875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance and prospects of study on molecular alterations in oligodendrogliomas].
    Gresner SM; Liberski PP
    Neurol Neurochir Pol; 2007; 41(4):333-9. PubMed ID: 17874342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oligodendrogliomas: their morphological characteristics and molecular alterations].
    Carrato-Monino C; Ariza A
    Rev Neurol; 2007 Mar 16-31; 44(6):353-9. PubMed ID: 17385172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma.
    Sahm F; Reuss D; Koelsche C; Capper D; Schittenhelm J; Heim S; Jones DT; Pfister SM; Herold-Mende C; Wick W; Mueller W; Hartmann C; Paulus W; von Deimling A
    Acta Neuropathol; 2014 Oct; 128(4):551-9. PubMed ID: 25143301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 33-2004. A 34-year-old man with a seizure and a frontal-lobe brain lesion.
    Eskandar EN; Loeffler JS; O'Neill AM; Hunter GJ; Louis DN
    N Engl J Med; 2004 Oct; 351(18):1875-82. PubMed ID: 15509821
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.